Scarica l'app Stockscreener
0.00
100.00%
-3.20
Precedente Chiudi:
$3.20
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$75.50M
Reddito:
$709.00K
Utile/perdita netta:
$-43.14M
Rapporto P/E:
0.00
EPS:
-4.54
Flusso di cassa netto:
$-20.35M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$4.75
OncoCyte Corporation Stock (OCX) Company Profile
Nome
OncoCyte Corporation
Settore
Industria
Telefono
510-775-0515
Indirizzo
1010 Atlantic Avenue, Suite 102, Alameda, CA
Confronta OCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCX
OncoCyte Corporation
|
0.00 | 75.50M | 709.00K | -43.14M | -20.35M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
OncoCyte Corporation Stock (OCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-28 | Iniziato | Lake Street | Buy |
| 2022-05-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-03-17 | Ripresa | Needham | Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | Iniziato | BTIG Research | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | Reiterato | The Benchmark Company | Speculative Buy |
| 2020-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | Iniziato | Needham | Buy |
| 2019-02-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-01-29 | Aggiornamento | Janney | Neutral → Buy |
| 2018-12-19 | Ripresa | Lake Street | Buy |
Mostra tutto
OncoCyte Corporation Borsa (OCX) Ultime notizie
What MACD signals say about OncoCyte Corporation2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Will a bounce in OncoCyte Corporation offer an exitTake Profit & Weekly High Return Forecasts - Newser
Is OncoCyte Corporation reversing from oversold territoryAnalyst Upgrade & Momentum Based Trading Signals - Newser
What indicators show strength in OncoCyte Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
Is OncoCyte Corporation trending in predictive chart modelsQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
How to build a dashboard for OncoCyte Corporation stock2025 Market Trends & Weekly Market Pulse Updates - Newser
OncoCyte Corporation (NASDAQ:OCX) Q4 2024 Earnings Call Transcript - MSN
OncoCyte Corporation Crosses 200 Day MA — Signal or NoiseWeekly Profit Analysis & Verified Swing Trading Watchlist - 선데이타임즈
Can OncoCyte Corporation hit a new high this monthWeekly Profit Summary & Verified Swing Trading Watchlist - Newser
Using Bollinger Bands to evaluate OncoCyte CorporationJuly 2025 Selloffs & Weekly Momentum Picks - Newser
Statistical indicators supporting OncoCyte Corporation’s strengthWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Can OncoCyte Corporation recover in the next quarter2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Reversal indicators forming on OncoCyte Corporation stockChart-Based Entry Confirmation for Beginners - Newser
OncoCyte Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingBond Market & Safe Entry Point Alerts - Newser
Why OncoCyte Corporation stock attracts strong analyst attentionStable Swing Setup with Safety Analysis - Newser
Is OncoCyte Corporation stock overhyped or has real potentialTechnical Long-Term Outlook and Recap Guide - Newser
Combining machine learning predictions for OncoCyte CorporationExpert-Backed High Yield Stock Watchlist - Newser
Top chart patterns to watch in OncoCyte CorporationEarly Buy Opportunity with Chart Triggers - Newser
What MACD and RSI say about OncoCyte CorporationScalable Strategy with Chart Confirmation - Newser
Using economic indicators to assess OncoCyte Corporation potentialFree Accurate Technical Trend Reversal Picks - Newser
Using data filters to optimize entry into Amgen Inc.Entry Optimization Tool with Screener Logic - Newser
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
How OncoCyte Corporation stock performs during market volatilityWeekly Entry Signal Based Forecast Tool - Newser
Will OncoCyte Corporation benefit from macro trendsFree Low Risk Equity Screener With Results - Newser
Advanced analytics toolkit walkthrough for OncoCyte CorporationChart Confirmation Setup with ROI Signals - Newser
Detecting support and resistance levels for OncoCyte CorporationInvestment Timeline and ROI Summary Report - Newser
Is It Too Late to Sell OncoCyte CorporationConservative Long Term Growth Plans Under Review - beatles.ru
What to expect from OncoCyte Corporation in the next 30 daysMomentum Entry Alerts with Risk Control - Newser
Is OncoCyte Corporation building a consolidation baseAI-Powered Stock Trend Movement Analysis - Newser
OncoCyte Corporation’s volatility index tracking explainedLong-Term Stock Growth Forecast Insights - Newser
What makes OncoCyte Corporation stock price move sharplyScalable Strategy with Chart Confirmation - Newser
Should I buy OncoCyte Corporation stock before earningsTrading Volume Spike and Reversal Analysis - Newser
What technical models suggest about OncoCyte Corporation’s comebackBuy/Sell Zone Confirmation Technical Analysis - Newser
OncoCyte Corporation Azioni (OCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):